International
Albania
Bosnia and Herzegovina
Bulgaria
Croatia
Czech Republic
Estonia
Hungary
Latvia
Lithuania
Kosovo
North Macedonia
Poland
Romania
Serbia
Slovakia
Slovenia
Switzerland (German)
Switzerland (French)
Meedia
Kohtuge meiega
Karjäär
Võta meiega ühendust
Meie portfell
Ravimid
Käsimüügiravimid ja toidulisandid
Partnerid ja brändid
Tagasiside
Ewopharmast
Visioon/missioon
Meie väärtused
Meie strateegia
Juhtimine
Ettevõtte vastutus
Piirkond
Meedia
Kohtuge meiega
Karjäär
Võta meiega ühendust
International
Albania
Bosnia and Herzegovina
Bulgaria
Croatia
Czech Republic
Estonia
Hungary
Latvia
Lithuania
Kosovo
North Macedonia
Poland
Romania
Serbia
Slovakia
Slovenia
Switzerland (German)
Switzerland (French)
Meedia
Pressiteated
1
2
3
Järgmine
15.04.2026
Sugemalimab Receives I, A Recommendation in ESMO Guideline for Consolidation Therapy in Patients with Stage Ⅲ NSCLC
Loe lisa
26.02.2026
BioGaia AB extends long-standing distribution partnership with Ewopharma
Loe lisa
16.12.2025
Sugemalimab Achieves New Regulatory Milestone: European Commission Approves Stage Ⅲ NSCLC Indication
Loe lisa
26.07.2024
European Commission Approves Sugemalimab
Loe lisa
03.06.2024
AllergyCare AG becomes part of Ewopharma Group
Loe lisa
1
2
3
Järgmine
![[Translate to Estonia:]](/fileadmin/user_upload/Ewopharma_CStone_Sugemalimab_01.png "[Translate to Estonia:]")
